Reduces the chance of endophthalmitis by five folds.
Prevents postoperative anterior chamber reactions.
Safe and compatible to Corneal endothelial cells.
Remote chances of bacterial resistance.
Ready to use and economical.
icMox PFS is indicated as prophylaxis antibiotic in preventing postoperative anterior chamber reaction and ultimately endophthalmitis in cataract extraction
icMox PFS is indicated as prophylaxis antibiotic in preventing postoperative anterior chamber reaction and ultimately endophthalmitis in cataract extraction